FDA Inspection 1314884 — Dr. Nagaraju Boyilla, M.D.
The FDA completed an inspection of Dr. Nagaraju Boyilla, M.D. on Mar 28, 2026 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 28, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional details
Clinical BA/BE